Resources
Contact
Email Alerts
FAQ
What does Precigen do?
Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cellular therapies using precision technology to target the most urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases.
Where is Precigen’s headquarters?
Precigen’s headquarters are located at:
20358 Seneca Meadows Parkway
Germantown, Maryland 20876
Telephone (301) 556-9900
20358 Seneca Meadows Parkway
Germantown, Maryland 20876
Telephone (301) 556-9900
On what exchange does Precigen trade and what is its stock symbol?
Shares of Precigen trade on the NASDAQ global select market exchange under the symbol PGEN.
Can shares of Precigen be purchased directly through the Company?
No, Precigen does not offer a direct investment program. Interested investors may purchase shares through any registered broker.
When is Precigen’s fiscal year end?
Precigen’s fiscal year end is December 31.
When is Precigen’s next earnings release?
Precigen reports earnings results on a quarterly basis. For our upcoming earnings announcements and other investor events, please see our calendar of events.
Who are Precigen’s directors?
The names of Precigen’s directors can be found in the Governance section of the website.
Who is Precigen’s independent auditor?
Precigen’s independent auditor is Deloitte & Touche LLP.
Who is Precigen’s transfer agent?
Precigen’s transfer agent is:
American Stock Transfer & Trust Company LLC
6201 15th Avenue, Brooklyn, NY 11219
(800) 937-5449
American Stock Transfer & Trust Company LLC
6201 15th Avenue, Brooklyn, NY 11219
(800) 937-5449
Who do I contact to request information on my account or change my account information?
For questions concerning stock holdings, certificate replacement/transfer, and address changes, please contact our transfer agent:
American Stock Transfer & Trust Company LLC
6201 15th Avenue, Brooklyn, NY 11219
(800) 937-5449
American Stock Transfer & Trust Company LLC
6201 15th Avenue, Brooklyn, NY 11219
(800) 937-5449
How do I access information on Precigen’s SEC filings? How can I obtain a copy of the annual report?
Annual 10-K reports, quarterly 10-Q reports, proxy statements and other filings with the SEC can be accessed directly through the SEC filings section of Precigen’s website or through the Securities and Exchange Commission at SEC.gov. If you would like a hard copy of the annual report, please submit your request through our Contact Form.
Where can I find more information regarding my shareholder rights and the proxy voting process?
Shareholders can access general educational information on shareholder rights in the proxy voting process on third-party sites below are several links that may be helpful to shareholders:
- S. Securities and Exchange Commission--Spotlight on Proxy Matters: https://sec.gov/spotlight/proxymatters.shtml
- S. Securities and Exchange Commission--Investor Alerts on New Shareholder Voting Rules for the 2010 Proxy Season: https://sec.gov/investor/alerts/votingrules2010.htm
How may an interested party communicate with the lead independent director or with the independent directors?
Interested parties may contact these persons as directed in Appendix B to our Corporate Governance Guidelines.
How can I find information on career opportunities with Precigen?
For information on career opportunities at Precigen, please visit the Careers section of Precigen’s website.
Do you have further questions concerning Precigen that have not been answered?
Go to the Investor Contact page.